title: Use of Ber-EP4 and Epithelial Specific Antigen to Differentiate Clinical Simulators of Basal Cell Carcinoma.
abstract: EpCam is a transmembrane epithelial adhesion molecule present on all non-squamous epithelial cells. It is often overexpressed in certain carcinomas, such as breast and colon, and in dermatology, eg, basal cell carcinoma (BCC). Various monoclonal antibodies have been used to detect EpCam, including BerEP4 and epithelial specific antigen. We compared anti-EpCam clones, BerEP4, and epithelial specific antigen clone VU-1D9. One hundred and twelve lesions were stained with both antibodies. All basal cell carcinomas stained uniformly and strongly positive with both antibodies. Diffuse positive staining was also seen in all trichoepitheliomas and merkel cell carcinomas. Focal positive staining was seen in squamous cell carcinoma and benign sebaceous neoplasms. Clone VU-1D9 was more likely to produce focal positive staining as compared to BerEP4. This focal positive staining of sebaceous neoplasms and squamous cell carcinomas is a potential diagnostic pitfall.
authors.affiliation: Memorial Sloan Kettering Cancer Center, Department of Medicine, Dermatology Service, New York, NY, USA.
authors.forename: Bahar
authors.initials: B
authors.lastname: Dasgeb
authors.forename: Tarana M
authors.initials: TM
authors.lastname: Mohammadi
authors.forename: Darius R
authors.initials: DR
authors.lastname: Mehregan
keywords: BerEP4; EpCam; basal cell carcinoma; merkel cell carcinoma; squamous cell carcinoma